NCT00005869View on ClinicalTrials.gov

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

rubitecan

Trial Locations (1)

94568

SuperGen, Incorporated, Dublin

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY